StockData
Oncolytics Biotech Inc logo

Oncolytics Biotech Inc (ONCY) stock

ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.44+0.06 (+15.11%)

Close on Nov 18, 2026Market cap $56.14MP/E –Yield –

Oncolytics Biotech revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2021 it was C$0. The highest annual figure on record is C$6.18M in fiscal 2017.

Annual revenue

PeriodPeriod endValueChange
FY2021Dec 31, 2021C$0–
FY2020Dec 31, 2020C$0–
FY2019Dec 31, 2019C$0-100.0%
FY2018Dec 31, 2018C$547.71K-91.1%
FY2017Dec 31, 2017C$6.18M–

More Oncolytics Biotech figures

See a number that looks wrong?